Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-12 Purchase | 2023-10-12 5:09 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $8.37 | $41,850 | 19,429 (Direct) | View |
| 2023-08-23 Sale | 2023-08-25 9:28 pm | iTeos Therapeutics Inc. | ITOS | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Davis Aaron I. See remarks | 350,000 | $16.26 | $5,692,673 | 1,804,058 (Direct) | View |
| 2022-06-08 Sale | 2022-06-10 7:51 pm | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 29,615 | $20.17 | $597,214 | 494,077 (Direct) | View |
| 2022-05-09 Sale | 2022-05-11 9:15 pm | iTeos Therapeutics Inc. | ITOS | Davis Aaron I. Director | 663,000 | $21.04 | $13,949,234 | 2,154,058 (Indirect) | View |
| 2022-04-28 Sale | 2022-05-02 9:15 pm | iTeos Therapeutics Inc. | ITOS | Davis Aaron I. Director | 375,000 | $27.33 | $10,247,871 | 2,817,058 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-08 8:01 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 163,200 | $0 | 163,200 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 8:00 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:58 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 153,600 | $0 | 153,600 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:57 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 590,400 | $0 | 590,400 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-07 8:01 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | DeSimone Jill Director | 44,766 | $0 | 44,766 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:22 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 31,000 | $0 | 31,000 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:22 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 44,000 | $0 | 137,898 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:21 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 41,000 | $0 | 60,429 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:20 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 30,000 | $0 | 58,903 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:17 pm | N/A 2033-12-05 | iTeos Therapeutics Inc. | ITOS | Lee David K Director | 44,766 | $0 | 44,766 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:57 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Van Hauwermeiren Timothy Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:56 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | RHOADS ANN D Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:55 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:55 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Ho Tony W Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:54 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:53 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | DiRocco Derek Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:52 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Davis Aaron I. Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-29 8:00 pm | N/A 2029-12-04 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 40,226 | $0 | 201,762 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-29 8:00 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 40,226 | $2.95 | 201,762 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:54 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:53 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Lager Joanne Jenkins Chief Medical Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:53 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:52 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:51 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 346,000 | $0 | 692,000 (Direct) | View |
| 2023-03-09 Gift | 2023-03-10 7:51 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 509,994 | $0 | 692,000 (Direct) | View |
| 2022-04-15 Ownership | 2023-03-10 7:50 pm | N/A 2032-03-11 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 528,750 | $0 | 352,500 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 8:30 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 17,538 | $0 | 17,538 (Indirect) | View |
| 2022-06-09 Option Award | 2022-06-10 7:57 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | Van Hauwermeiren Timothy Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:56 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | RODEN MATTHEW Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:54 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | RHOADS ANN D Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:53 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:52 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | Ho Tony W Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:51 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 17,538 | $0 | 494,077 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 7:51 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 29,615 | $0 | 494,077 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 7:51 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 11,899 | $2.95 | 494,077 (Direct) | View |
| 2022-06-08 Exercise | 2022-06-10 7:51 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 17,716 | $4.23 | 494,077 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:48 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | DiRocco Derek Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:47 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | Davis Aaron I. Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:46 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | Biniszkiewicz Detlev Director | 17,538 | $0 | 17,538 (Direct) | View |